Vanguard C4 Injectable Live Vaccine for Dogs

Negara: Australia

Bahasa: Inggris

Sumber: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Bahan aktif:

CANINE DISTEMPER VIRUS; CANINE PARAINFLUENZA VIRUS; CANINE ADENOVIRUS TYPE 2 LIVE (CAV II); CANINE PARVOVIRUS - LIVE; GENTAMICIN

Tersedia dari:

ZOETIS AUSTRALIA PTY LTD

Bentuk farmasi:

MISC. VACCINES OR ANTI SERA

Komposisi:

CANINE DISTEMPER VIRUS VACCINE-VIRAL Active 0.0 U; CANINE PARAINFLUENZA VIRUS VACCINE-VIRAL Active 0.0 U; CANINE ADENOVIRUS TYPE 2 LIVE (CAV II) VACCINE-VIRAL Active 0.0 U; CANINE PARVOVIRUS - LIVE VACCINE-VIRAL Active 0.0 U; GENTAMICIN ANTIBIOTIC Other 30.0 ug/ml

Unit dalam paket:

25x1 dose

Kelas:

VM - Veterinary Medicine

Area terapi:

IMMUNOTHERAPY

Ringkasan produk:

Poison schedule: 4; Withholding period: ; Host/pest details: DOG - OVER 6 WEEKS OLD: [CANINE ADENOVIRUS - TYPE 1, CANINE ADENOVIRUS - TYPE 2, CANINE DISTEMPER VIRUS, CANINE PARAINFLUENZA VIRUS, CANINE PARVOVIRUS]

Status otorisasi:

Registered

Tanggal Otorisasi:

2023-07-01

Selebaran informasi

Vanguard C4 Injectable Live Vaccine for Dogs
82596/140807
Product Name:
APVMA Approval No:
Label Name:
Vanguard C4 Injectable Live Vaccine for Dogs
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Each dose contains live attenuated:
Canine distemper virus (≥ 10^2.2 TCID50)
Canine adenovirus type 2 (≥ 10^2.7 TCID50)
Canine parvovirus (≥ 10^6.7 TCID50)
Canine parainfluenza virus (≥ 10^4.7 TCID50)
Also contains: ≤ 30 µg/mL gentamicin
Claims:
For use only by or under supervision of a veterinarian.
For vaccination of healthy dogs 6 weeks of age or older as an aid in
preventing canine
distemper caused by canine distemper (CD) virus, infectious canine
hepatitis (ICH) caused
by canine adenovirus type 1 (CAV-1), respiratory disease caused by
canine adenovirus
type 2 (CAV-2), canine parvoviral enteritis caused by canine
parvovirus (CPV), and canine
parainfluenza caused by canine parainfluenza (CPI) virus.
Vanguard C4 provides cross-protection against canine parvovirus
subtypes CPV-2a,
CPV-2b and CPV-2c and induces virus neutralizing antibodies against
Australian strains of
these three subtypes.
Net Contents:
[25 x 1 dose vial]
[25 x 1 dose vial, 25 x 1 mL sterile diluent]
Directions for Use:
Restraints:
Contraindications: RLP APPROVED
Precautions:
Use with caution in breeding and lactating dogs as the safety of
Vanguard C4 has not been
evaluated under these conditions.
Side Effects:
Systemic allergic reactions such as anaphylaxis may occur after use
and may require
appropriate treatment. Some animals may show systemic hypersensitivity
reactions, mainly
characterised by facial oedema and urticaria. Some animals may show
transient post-
vaccination reactions including injection site pain, lethargy,
diarrhoea and/or vomiting.
Dosage and
Administration:
Use reconstituted vaccine immediately.
For subcutaneous use only.
Only healthy animals should be vaccinated.
Preparation of vaccine:
Aseptically reconstitute the
Vanguard
C4 freeze-dried vacci